Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Iron sucrose + ferrous lactate describes a combination of two distinct iron-containing compounds. However, a single pharmaceutical product containing both iron sucrose and ferrous lactate does not exist. This is because they are administered via different and incompatible routes. * **Iron sucrose** is a macromolecular complex of iron(III) hydroxide and sucrose. It is administered exclusively by intravenous (IV) injection or infusion to treat iron deficiency anemia, particularly in patients with chronic kidney disease. [4, 5, 6] Brand names for iron sucrose include Venofer. [6] * **Ferrous lactate** is a salt of iron(II) and lactic acid. It is administered orally as a tablet, capsule, or liquid solution to treat and prevent iron deficiency. [2, 3, 12] It is known for its good bioavailability and is often considered gentler on the gastrointestinal system compared to other oral iron salts like ferrous sulfate. [1, 10] Since one component is for intravenous use and the other is for oral use, they are not co-formulated into a single medication.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on iron sucrose + ferrous lactate.